Comprehensive analysis of Aditya Birla SL Nifty 50 EWI Fund - Direct (IDCW) (42081) providing detailed insights into fund performance, portfolio holdings, risk metrics, expense ratios, and investment recommendations.
Aditya Birla Sun Life AMC Ltd
The investment objective of the scheme is to provide returns that closely correspond to the total returns of securities as represented by Nifty 50 Equal Weight TR Index, subject to tracking errors. The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes' objectives will be achieved.
A comprehensive at-a-glance view of key mutual fund health indicators
Moderate Returns
High Risk
Low Expense Ratio
Equity Focused
Established Team
Average Quality
Showing 1Y NAV history
Performance across different time periods
Fund shows mixed signals. Consider your investment timeline and risk tolerance.
Review detailed analysis and consider dollar-cost averaging through SIPs.
Fund shows mixed signals. Consider your investment timeline and risk tolerance.
Review detailed analysis and consider dollar-cost averaging through SIPs.
Market exposure level
Outperformance vs benchmark
Recent performance momentum
Fund management costs
Historical performance consistency
Fund manager experience
Risk-adjusted returns
Assets under management
This fund has underperformed its benchmark by 0.54% over the 3Y period.
See how your money can grow and compare with popular investment options
Disclaimer: Returns are illustrative and based on assumed rates. Mutual fund investments are subject to market risk. Please read scheme documents carefully.
| Company | Sector | % Assets |
|---|---|---|
| Eternal Ltd | E-Commerce/App based Aggregator | 2.42% |
| Hindustan Unilever Ltd | FMCG | 2.26% |
| Jio Financial Services Ltd | Finance | 2.21% |
| Apollo Hospitals Enterprise Ltd | Healthcare | 2.17% |
| Asian Paints Ltd | Paints/Varnish | 2.14% |
| UltraTech Cement Ltd | Cement | 2.13% |
| Jio Financial Services Ltd | Finance | 2.12% |
| ICICI Bank Ltd | Banks | 2.12% |
| Cipla Ltd | Pharmaceuticals | 2.10% |
| JSW Steel Ltd | Steel | 2.09% |
Compare against Index Fund category average
This comparison shows how the fund performs relative to the Index Fund category average. Positive values indicate outperformance, while negative values show underperformance.
Compare with similar funds in Index Fund category
| Fund Name | NAV | 6M | 1Y | 3Y |
|---|---|---|---|---|
| Invesco India Nifty G-sec Sep 2032 Index Fund-Dir (IDCW) | ₹1233.29 | 6.17% | 11.30% | N/A |
| Invesco India Nifty G-sec Sep 2032 Index Fund-Dir (G) | ₹1233.29 | 6.17% | 11.30% | N/A |
| Invesco India Nifty G-sec Sep 2032 Index Fund-Reg (G) | ₹1229.16 | 6.09% | 11.14% | N/A |
| Invesco India Nifty G-sec Sep 2032 Index Fund-Reg (IDCW) | ₹1229.15 | 6.09% | 11.14% | N/A |
| Invesco India Nifty G-sec Jul 2027 Index Fund-Dir (G) | ₹1199.62 | 4.94% | 9.12% | N/A |
| Invesco India Nifty G-sec Jul 2027 Index Fund-Dir (IDCW | ₹1199.62 | 4.94% | 9.12% | N/A |
| Invesco India Nifty G-sec Jul 2027 Index Fund-Reg (IDCW) | ₹1195.53 | 4.86% | 8.96% | N/A |
| Invesco India Nifty G-sec Jul 2027 Index Fund-Reg (G) | ₹1195.51 | 4.86% | 8.96% | N/A |
| HDFC BSE Sensex Index Fund - Direct | ₹790.24 | 7.25% | 6.29% | 17.66% |
| HDFC BSE Sensex Index Fund - Regular | ₹771.61 | 7.17% | 6.12% | 17.46% |
A seasoned investment professional with over 4 years of experience in equity research and fund management. Known for consistent performance and a disciplined investment approach focused on quality growth stocks.